# The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections

> **NCT06311019** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Klavs Würgler Hansen** · enrollment: 104 (estimated)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DEVICE:** Continuous glucose monitoring and use of connected insulinpen for bolus insulin

## Key facts

- **NCT ID:** NCT06311019
- **Lead sponsor:** Klavs Würgler Hansen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-27
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2024-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06311019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06311019, "The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06311019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
